Gemcitabine cisplatin nasopharyngeal
WebSelect search scope, currently: articles+ all catalog, articles, website, & more in one search; catalog books, media & more in the Stanford Libraries' collections; articles+ journal articles & other e-resources WebJul 16, 2024 · Nasopharyngeal carcinoma (NPC) is a malignant tumor that occurs in the roof and side walls of the nasopharyngeal cavity, and the incidence rate is the first among otorhinolaryngology malignant tumors. Common clinical symptoms are nasal congestion, blood in the snot, ear stuffiness, hearing loss, diplopia, and headache.
Gemcitabine cisplatin nasopharyngeal
Did you know?
Webgemcitabine: [ jem-sit´ah-bēn ] an antineoplastic agent used in chemotherapy for pancreatic adenocarcinoma and non–small cell lung carcinoma ; administered by intravenous … WebDepartment of Radiation Oncology, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China. Tel +86 28 8542 3278. Fax +86 28 8542 2952. Email [email protected]. Abstract: Nasopharyngeal carcinoma (NPC) is rare in Western countries, but its incidence in China and Southeast Asia is notably high.
WebSep 2, 2024 · Patients in active comparator arm will receive induction chemotherapy with gemcitabine (1g/m2, d1 & 8 of every cycle) and cisplatin (80mg/m2, d1 of every cycle), every 3 weeks for 3 cycles before radiation. WebMar 9, 2024 · The purpose of this study was to compare the efficacy and toxicity of induction chemotherapy (IC) plus radiotherapy (RT) and IC plus concurrent or adjuvant chemoradiotherapy (CCRT/AC) in nasopharyngeal carcinoma (NPC) patients with negative Epstein–Barr virus DNA (EBV DNA) after IC. A total of 547 NPC patients with …
WebApr 6, 2024 · This was a multi-center, single-arm study that enrolled MIBC patients with a clinical stage of T2-4aN0-1M0, and scheduled for RC. Patients received three 21-day cycles of camrelizumab 200 mg on day 1, gemcitabine 1000 mg/m 2 on day 1 and 8, and cisplatin 70 mg/m 2 on day 2, followed by RC. The primary endpoint was pathologic … WebGEMCITABINE-CISPLATIN is used to treat: Biliary tract cancer. Bladder cancer. Cervical cancer. Malignant mesothelioma. Non-small cell lung cancer (NSCLC). Ovarian cancer. …
WebSep 3, 2024 · Synergistic effect of gemcitabine and cisplatin on DNA damage in HONE1 and SUNE1 cells. (A) After HONE1 and SUNE1 cells were treated with GEM, DDP, or …
WebJun 3, 2024 · Leong SS, Wee J, Rajan S, et al. Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma. Cancer. 2008;113:1332–7. CrossRef CAS PubMed Google Scholar. Zhang L, Huang Y, Hong S, et al. Gemcitabine plus cisplatin … indian arbitration clause sampleWebGEMCITABINE-CISPLATIN (jem-SY-tuh-been-sis-PLA-tin) This chemotherapy combination contains the drugs gemcitabine and cisplatin. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways. Drugs in the GEMCITABINE-CISPLATIN combination: Gemcitabine Hydrochloride Cisplatin l oasis bou y’aWebAug 23, 2016 · Gemcitabine is a pyrimidine analogue and a ribonucleotide reductase inhibitor that has a broad spectrum of antitumour activity. The synergistic cytotoxic effects between gemcitabine and cisplatin seen in … indian archaeology multiple choice questionsWebNational Center for Biotechnology Information indian archaeology pdfWebJun 3, 2024 · New Drug Toripalimab Improves Survival in Nasopharyngeal Cancer. A new immunotherapy, toripalimab, has the potential to change practice in the treatment of … indian archeryWebMay 31, 2024 · Previous phase 2 trials have shown that gemcitabine plus cisplatin is an effective chemotherapy in patients with nasopharyngeal … indian archery bow stringWebZhang LI, Huang Y, Hong S, et al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open‐label, phase 3 trial. loasis infection